Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth

Oncology Reports

Volumn 24, Issue 6, 2010, Pages 1551-1559

  Xue, Yan ^a   Li, Lei ^a   Zhang, Dong ^a   Wu, Kaijie ^a   Guo, Peng ^a   Zeng, Jin ^a   Wang, Xinyang ^a   He, Dalin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bladder cancer; p53; Promyelocytic leukemia protein; Telomerase; Telomerase reverse transcriptase

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE H1; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P21; PROTEIN P53; SHORT HAIRPIN RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CELL CYCLE ARREST; CELL IMMORTALIZATION; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TELOMERE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MICE; MICE, NUDE; NUCLEAR PROTEINS; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; TELOMERASE; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78649439804     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001017     Document Type: Article

References (34)

1. Razak ZR, Varkonyi RJ, Kulp-McEliece M, Caslini C, Testa JR, Murphy ME and Broccoli D: p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance. Mol Cell Biol 24: 5967-5977, 2004.
2. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
3. McEachern MJ, Krauskopf A and Blackburn EH: Telomeres and their control. Annu Rev Genet 34: 331-358, 2000.
4. Nakayama J, Tahara H, Tahara E, et al: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18: 65-68, 1998.
5. Zhang X, Mar V, Zhou W, Harrington L and Robinson MO: Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 15: 2388-2399, 1999.
6. Chang S and DePinho RA: Telomerase extracurricular activities. Proc Nati Acad Sci USA 99: 12520-12522, 2002.
7. Melnick A and Licht JD: Deconstructing a disease: RARalpha, its function partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167-3215, 1999.
8. Bernardi R and Pandolfi PP: Structures, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006-1016, 2007.
9. Zhong S, Salomoni P and Pandolfi PP: The transcriptional role of PML and the nuclear body. Nat Cell Biol 2: E85-E90, 2000.
10. He DL, Zhu AJ and Wang HY: Expression of PML growth suppressor in bladder cancer. Natl Med J Chin 81: 881-882, 2001.
11. Li L, He DL, He H, Wang XY, Zhang LL, Luo Y and Nan XY: Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway. Cancer Lett 236: 259-268, 2006.
12. Borden KL: Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol 22: 5259-5269, 2002.
13. Lansdorp PM, Verwoerd NP, Van de Rijke FM, et al: Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5: 685-691, 1996.
14. Li L, Zhang D, Zhang LL, et al: PrlZ expression is associated with the progression of prostate cancer LNCaP cells. Mol Carcinog 48: 432-440, 2009.
15. Zhu G, Zhau HE, He H, et al: Sonic and desert hedgehog signaling in human fetal prostate development. Prostate 67: 674-684, 2007.
16. Santiago AR, Cristovao AJ, Santos PF, Carvalho CM and Ambrosio AF: High glucose induces caspase-independent cell death in retinal neural cells. Neurobiol Dis 25: 464-472, 2007.
17. Ledgerwood EC and Morison IM: Targeting the apoptosome for cancer therapy. Clin Cancer Res 15: 420-424, 2009.
18. Shen TH, Lin HK, Scaglioni PP, Yung TM and Pandolfi PP: The mechanisms of PML-nuclear body formation. Mol Cell 24: 331-339, 2006.
19. Xu D, Wang Q, Gruber A, et al: Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 19: 5123-5133, 2000.
20. Salomoni P and Pandolfi PP: The role of PML in tumor suppression. Cell 108: 165-170, 2002.
21. Kraemer K, Fuessel S, Schmidt U, Kotzsch M, Schwenzer B, Wirth MP and Meye A: Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res 9: 3794-3800, 2003. (Pubitemid 37169250)
22. Zhang P, Chen Y, Jiang X, Tu Z and Zou L: Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter. Oncol Rep 23: 1309-1316, 2010.
23. Liu JP: Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 13: 2091-2104, 1999.
24. Zhu H, Fu W and Mattson MP: The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem 75: 117-124, 2000.
25. Cao Y, Li H, Mu FT, Ebisui O, Funder JW and Liu JP: Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J 16: 1096-1098, 2002.
26. Bernardi R and Pandolfi PP: Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22: 9048-9057, 2003.
27. Jiang WQ, Zhong ZH, Henson JD and Reddel RR: Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene 26: 4635-4647, 2007.
28. Oh W, Ghim J, Lee EW, Yang MR, Kim ET, Ahn JH and Song J: PML-IV functions as a negative regulator of telomerase by interacting with TERT. J Cell Sci 122: 2613-2622, 2009.
29. Gurrieri C, Capodieci P, Bernardi R, et al: Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Nati Cancer Inst 96: 269-279, 2004.
30. Yang CH, Hung WC, Wang SL, et al: Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma. APMIS 116: 309-316, 2008.
31. Li H, Cao Y, Berndet MC, Funder JW and Liu JP: Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene 18: 6785-6794, 1999.
32. Pearson M, Carbone R, Sebastiani C, et al: PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210, 2000.
33. Fogal V, Gostissa M, Sandy P, et al: Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 19: 6185-6195, 2000.
34. Guo A, Salomoni P, Luo J, Shin A, Zhong S, Gu W and Pandolfi PP: The funtion of PML in p53-dependent apoptosis. Nat Cell Biol 2: 730-736, 2000.